However, Bachman et al. showed that single Exon 20 mutations (H1047R) were more frequent [35], similar to the study by Castañeda et al. in Peruvian women with HER-2-positive and triple-negative BC [32]. The gene discussed is ERBB2; the disease is breast cancer.